The Moving Average Convergence Divergence (MACD) for PIII turned positive on October 22, 2026. Looking at past instances where PIII's MACD turned positive, the stock continued to rise in 30 of 35 cases over the following month. The odds of a continued upward trend are 86%.
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where PIII's RSI Indicator exited the oversold zone, 32 of 42 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 76%.
Following a +9.82% 3-day Advance, the price is estimated to grow further. Considering data from situations where PIII advanced for three days, in 197 of 233 cases, the price rose further within the following month. The odds of a continued upward trend are 85%.
PIII may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where PIII declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The Aroon Indicator for PIII entered a downward trend on October 22, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron PE Growth Rating for this company is 8 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 43 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (-0.185) is normal, around the industry mean (204.132). P/E Ratio (-0.132) is within average values for comparable stocks, (18.957). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.498). Dividend Yield (0.000) settles around the average of (0.100) among similar stocks. P/S Ratio (0.017) is also within normal values, averaging (2.688).
The Tickeron Price Growth Rating for this company is 65 (best 1 - 100 worst), indicating fairly steady price growth. PIII’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PIII’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 85, placing this stock worse than average.
The Moving Average Convergence Divergence (MACD) for SGRY turned positive on October 12, 2026. Looking at past instances where SGRY's MACD turned positive, the stock continued to rise in 33 of 44 cases over the following month. The odds of a continued upward trend are 75%.
The Momentum Indicator moved above the 0 level on October 13, 2026. You may want to consider a long position or call options on SGRY as a result. In 62 of 87 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 71%.
SGRY moved above its 50-day moving average on October 13, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for SGRY crossed bullishly above the 50-day moving average on October 19, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 10 of 18 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 56%.
Following a +6.02% 3-day Advance, the price is estimated to grow further. Considering data from situations where SGRY advanced for three days, in 191 of 272 cases, the price rose further within the following month. The odds of a continued upward trend are 70%.
The RSI Indicator demonstrated that the stock has entered the overbought zone. This may point to a price pull-back soon.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 6 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
The 50-day moving average for SGRY moved below the 200-day moving average on October 05, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where SGRY declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 79%.
SGRY broke above its upper Bollinger Band on September 22, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron Seasonality Score of 20 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron PE Growth Rating for this company is 39 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 47 (best 1 - 100 worst), indicating steady price growth. SGRY’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 92 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 96 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.246) is normal, around the industry mean (204.132). P/E Ratio (-23.043) is within average values for comparable stocks, (18.957). SGRY's Projected Growth (PEG Ratio) (21.970) is very high in comparison to the industry average of (2.498). Dividend Yield (0.000) settles around the average of (0.100) among similar stocks. P/S Ratio (0.530) is also within normal values, averaging (2.688).
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SGRY’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 85, placing this stock worse than average.
SGRY | ||
|---|---|---|
OUTLOOK RATING 1..100 | 16 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 96 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | |
SMR RATING 1..100 | 92 | |
PRICE GROWTH RATING 1..100 | 47 | |
P/E GROWTH RATING 1..100 | 39 | |
SEASONALITY SCORE 1..100 | 20 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
| PIII | SGRY | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 76% | 1 day ago 90% |
| Stochastic ODDS (%) | N/A | 1 day ago 85% |
| Momentum ODDS (%) | N/A | 1 day ago 71% |
| MACD ODDS (%) | 1 day ago 86% | 1 day ago 75% |
| TrendWeek ODDS (%) | 1 day ago 85% | 1 day ago 69% |
| TrendMonth ODDS (%) | 1 day ago 90% | 1 day ago 67% |
| Advances ODDS (%) | 1 day ago 85% | 3 days ago 70% |
| Declines ODDS (%) | 10 days ago 90% | 7 days ago 79% |
| BollingerBands ODDS (%) | 1 day ago 82% | 1 day ago 89% |
| Aroon ODDS (%) | 1 day ago 90% | N/A |
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
PIII’s FA Score shows that 1 FA rating(s) are green while SGRY’s FA Score has 0 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
PIII’s TA Score shows that 3 TA indicator(s) are bullish while SGRY’s TA Score has 5 bullish TA indicator(s).
PIII (@Hospital/Nursing Management) experienced а -5.95% price change this week, while SGRY (@Hospital/Nursing Management) price change was +3.84% for the same time period.
The average weekly price growth across all stocks in the @Hospital/Nursing Management industry was +1.15%. For the same industry, the average monthly price growth was -3.02%, and the average quarterly price growth was +22.32%.
PIII is expected to report earnings on Nov 12, 2026.
SGRY is expected to report earnings on Nov 09, 2026.
Hospital/Nursing Management companies own and operate health care facilities. Their operations include nursing homes, acute care facilities, retirement centers and outpatient surgery centers. HCA Healthcare Inc., Alcon Inc. and Universal Health Services, Inc. are some major companies in this industry. Technology has been at the forefront of development of advanced solutions, including quicker diagnoses of complex conditions. Investments in new diagnostics, healthcare IoT, and other healthcare technologies continue to gather momentum in this industry.
A.I.dvisor tells us that PIII and ADUS have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PIII and ADUS's prices will move in lockstep.
| Ticker / NAME | Correlation To PIII | 1D Price Change % | ||
|---|---|---|---|---|
| PIII | 100% | +6.08% | ||
| ADUS - PIII | 24% Poorly correlated | +4.00% | ||
| SGRY - PIII | 23% Poorly correlated | +3.25% | ||
| ENSG - PIII | 21% Poorly correlated | +2.88% | ||
| OPCH - PIII | 21% Poorly correlated | N/A | ||
| HCSG - PIII | 21% Poorly correlated | +14.19% | ||
More | ||||
A.I.dvisor indicates that over the last year, SGRY has been loosely correlated with ASTH. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if SGRY jumps, then ASTH could also see price increases.
| Ticker / NAME | Correlation To SGRY | 1D Price Change % | ||
|---|---|---|---|---|
| SGRY | 100% | +3.25% | ||
| ASTH - SGRY | 37% Loosely correlated | +1.77% | ||
| CYH - SGRY | 34% Loosely correlated | +3.19% | ||
| THC - SGRY | 34% Loosely correlated | +0.56% | ||
| HCA - SGRY | 32% Poorly correlated | +1.72% | ||
| UHS - SGRY | 31% Poorly correlated | +2.88% | ||
More | ||||